Peptide Quality Control from Material Review to Batch Release
Peptide quality control is performed through documented material checks, in-process monitoring, analytical testing, data review, deviation assessment, and packaging verification. Consequently, a batch is evaluated against predefined specifications before release rather than being approved solely on the basis of appearance or a supplier statement.
Quality Is Controlled Across the Entire Batch Lifecycle
Quality control should not be limited to testing the finished powder. Instead, controls should be applied from material receipt through production, purification, testing, packaging, storage, and shipment.
Moreover, data should be reviewed in context. An unexpected chromatographic peak, an incorrect label, an incomplete record, or a temperature deviation may all require investigation even when the main purity result appears acceptable.
ICH Q7 recommends that appropriate laboratory tests be performed for each API batch, while production and control information should be retained in batch records. It also states that impurity profiles should be monitored to identify changes associated with materials, equipment, or process conditions.
Core Quality-Control Checkpoints
| Control Stage | Typical Review | Possible Record |
|---|---|---|
| Material Receipt | Identity, supplier, quantity and lot information | Receiving record |
| Production Preparation | Approved instructions, equipment and materials | Batch production record |
| In-Process Control | Defined process steps and critical observations | In-process checklist |
| Analytical Testing | Identity, purity and agreed quality attributes | Laboratory worksheet |
| Quality Review | Results, calculations, deviations and specifications | Review record |
| Packaging Check | Vial, label, quantity, batch code and storage text | Packaging record |
| Batch Release | Final document and acceptance review | Release authorization |
Deviations and Out-of-Specification Results
When an expected result is not obtained, the data should not simply be discarded or replaced. Instead, the event should be documented, the potential cause should be investigated, and the effect on product quality should be evaluated.
Therefore, the following issues may require formal review:
- results outside an approved specification;
- unusual chromatographic peaks;
- calculation or transcription errors;
- equipment malfunction;
- incomplete production records;
- incorrect labeling;
- unexpected temperature exposure;
- packaging damage or quantity discrepancy.
FDA states that CGMP data are expected to be reliable and accurate. Accordingly, effective controls should be implemented to prevent and detect data-integrity problems.
Quality-Control Workflow
Specifications Are Approved
Product identity, appearance, purity, quantity, testing, and packaging requirements are defined.
Records Are Generated
Production and testing activities are documented as they are performed.
Results Are Compared
Analytical data are compared with the applicable acceptance criteria.
Exceptions Are Investigated
Any deviation or unexpected result is recorded and assessed.
Batch Documents Are Reviewed
Subsequently, production, testing, packaging, and investigation records are checked.
Release Status Is Assigned
Finally, the batch is approved, rejected, held, or returned for further review.
Request Information About Our Quality-Control Process
Batch-testing scope, documentation availability, and product-specific specifications can be confirmed before ordering.